Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders

Recent studies have demonstrated that one-third of known microRNAs (miRNAs) are stably detectable in plasma. Therefore, we assessed plasma miRNAs to investigate the dynamics of oncomir 17-92a, which is highly expressed in multiple myeloma (MM) patients. The plasma miR-92a level in symptomatic MM pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshizawa, S, Ohyashiki, J H, Ohyashiki, M, Umezu, T, Suzuki, K, Inagaki, A, Iida, S, Ohyashiki, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270255/
https://www.ncbi.nlm.nih.gov/pubmed/22829237
http://dx.doi.org/10.1038/bcj.2011.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270255/
https://www.ncbi.nlm.nih.gov/pubmed/22829237
http://dx.doi.org/10.1038/bcj.2011.51

Ejemplares similares